Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1982
Degradation of exogenous enkephalin in the guinea-pig ileum: relative importance of aminopeptidase, enkephalinase and angiotensin converting enzyme activity
L E Geary, K S Wiley, W L Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1985
Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo
L G Mendelsohn, B G Johnson, W L Scott, et al.
The Journal of Laboratory and Clinical Medicine
|
June 1, 1986
Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation
W L Scott, C W Francis, D W Knutson, et al.
Cancer Research
|
October 15, 1991
Induction of immunogenicity of monoclonal antibodies by conjugation with drugs
D A Johnson, R L Barton, D V Fix, et al.
Life Sciences
|
April 1, 1985
Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition
W L Scott, L G Mendelsohn, M L Cohen, et al.
Combinatorial Chemistry & High Throughput Screening
|
September 24, 2005
Analytical and biological evaluation of high throughput screen actives using evaporative light scattering, chemiluminescent nitrogen detection, and accurate mass LC-MS-MS
D A Peake, D C Duckworth, T J Perun, et al.
Bioconjugate Chemistry
|
November 1, 1993
Protein conjugates of defined structure: synthesis and use of a new carrier molecule
L A Vilaseca, K Rose, R Werlen, et al.
Bioconjugate Chemistry
|
March 1, 1993
Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs
L D Apelgren, D L Bailey, S L Briggs, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2023
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
Michelle E Ramey, Firat Kaya, Allison A Bauman, et al.
Antimicrobial Agents and Chemotherapy
|
August 9, 2021
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
Gregory T Robertson, Michelle E Ramey, Lisa M Massoudi, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1982
Degradation of exogenous enkephalin in the guinea-pig ileum: relative importance of aminopeptidase, enkephalinase and angiotensin converting enzyme activity
L E Geary, K S Wiley, W L Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1985
Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo
L G Mendelsohn, B G Johnson, W L Scott, et al.
The Journal of Laboratory and Clinical Medicine
|
June 1, 1986
Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation
W L Scott, C W Francis, D W Knutson, et al.
Cancer Research
|
October 15, 1991
Induction of immunogenicity of monoclonal antibodies by conjugation with drugs
D A Johnson, R L Barton, D V Fix, et al.
Life Sciences
|
April 1, 1985
Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition
W L Scott, L G Mendelsohn, M L Cohen, et al.
Combinatorial Chemistry & High Throughput Screening
|
September 24, 2005
Analytical and biological evaluation of high throughput screen actives using evaporative light scattering, chemiluminescent nitrogen detection, and accurate mass LC-MS-MS
D A Peake, D C Duckworth, T J Perun, et al.
Bioconjugate Chemistry
|
November 1, 1993
Protein conjugates of defined structure: synthesis and use of a new carrier molecule
L A Vilaseca, K Rose, R Werlen, et al.
Bioconjugate Chemistry
|
March 1, 1993
Chemoimmunoconjugate development for ovarian carcinoma therapy: preclinical studies with vinca alkaloid-monoclonal antibody constructs
L D Apelgren, D L Bailey, S L Briggs, et al.
Antimicrobial Agents and Chemotherapy
|
October 4, 2023
Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model
Michelle E Ramey, Firat Kaya, Allison A Bauman, et al.
Antimicrobial Agents and Chemotherapy
|
August 9, 2021
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
Gregory T Robertson, Michelle E Ramey, Lisa M Massoudi, et al.
Page
of 2